CRYO CELL INTERNATIONAL INC. has set October 27, 2026 for its annual stockholder meeting and September 21, 2026 as the voting record date. The dates tell investors when the meeting will occur and which stockholders qualify for notice and voting, while July 27 deadlines govern proposals and director nominations.
Key Highlights
- Stockholders had until July 27, 2026, to submit Business for consideration at the annual meeting.
- David Portnoy signed the company’s report as chairman and co-CEO on September 14, 2026.
- CRYO CELL INTERNATIONAL’s 2026 annual stockholder meeting is set for October 27, 2026.
CRYO CELL INTERNATIONAL INC. (AMEX: CCEL) has set October 27, 2026, for its annual stockholder meeting and September 21, 2026, as the date for determining which stockholders are entitled to notice and voting rights.
Stockholders seeking to bring business before the meeting were required to provide notice by July 27, 2026, under the company’s bylaws. Director nominations for consideration at the meeting carried the same July 27 deadline.
Investor Insights
David Portnoy signed the report on September 14, 2026, in his roles as chairman and co-CEO. The company’s bylaws establish both notice requirements, covering proposed business and director nominations, for the annual meeting.
FAQs
Q: When is CRYO CELL INTERNATIONAL’s 2026 annual meeting?
A: CRYO CELL INTERNATIONAL’s 2026 annual stockholder meeting is set for October 27, 2026. The company also set September 21, 2026, as the record date.
Q: What is the CRYO CELL INTERNATIONAL record date?
A: September 21, 2026, is the record date for determining stockholders entitled to receive meeting notice and vote. The annual meeting is scheduled for October 27, 2026.
Q: What was the deadline for proposals and director nominations?
A: The deadline for timely notice of proposed business was July 27, 2026. Director nomination notices were subject to the same July 27 deadline under the company’s bylaws.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.